Special Drug Use-results Survey for Long-term Use（Avacopan）

Sponsor
Kissei Pharmaceutical Co., Ltd.
Study ID
NCT06758271
Status
Recruiting
Apply to this trial

Conditions

  • Granulomatosis With Polyangiitis (GPA)
  • Microscopic Polyangiitis (MPA)

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Key Dates

Start date
Jul 29, 2022
Status verified
Dec 2024
Primary completion
May 31, 2028
Completion
May 31, 2028

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: Avacopan treatmented

Primary Outcome Measure

Adverse events [ Time Frame: 2 years ]

Central Contacts

Related Studies